Monday, December 10, 2018

Is This the Deadliest Vaccine on the Market?



Manufactured Crisis — HPV, Hype and Horror





by Dr. Joseph Mercola


STORY AT-A-GLANCE

  • While the cervical cancer rate in the U.S. is 12 per 100,000, by Merck’s own admission, Gardasil may cause 2,300 serious adverse events per 100,000.
  • Many of the more serious side effects of Gardasil vaccination are immune-based inflammatory neurodegenerative disorders, suggesting something is causing the immune system to overreact in a detrimental way, sometimes fatally.
  • One of the leading theories is that the aluminum adjuvant in Gardasil is causing it to be excessively reactive. Data show Gardasil is several times more reactive than any other vaccine on the market.
  • Trial data from Merck shows Gardasil may increase your risk of cervical cancer by 44.6 percent if you have been exposed to HPV strains 16 or 18 prior to vaccination.
  • As of 2018, about 13,240 new cases of cervical cancer will be diagnosed, and about 4,170 will die from it. If you get regular Pap smears, your chance of dying from cervical cancer is 0.00002 percent.


Dr. Mercola's motivation, whether you are a member of the Mercola.com community or have just heard about him for the first time, is to make you as healthy as you can possibly be. This involves:
  • Providing the most up-to-date natural health information and resources that will most benefit you.
  • Exposing corporate, government and mass media hype that diverts you away from what is truly best for your health and often to a path that leads straight into an early grave.

Mercola.com is not, in other words, a tool to get him a bigger house and car, or to run for Senate. He funds his site and, therefore, is not handcuffed to any advertisers, silent partners or corporate parents.

When he offers or recommends products, he does so because he has actively researched them and find they are the best in that category for your health. He ignores substandard products, and products not directly pertinent to your health, regardless of any potential financial upside.  More information, here.

No comments:

Post a Comment